Join
Live feed
·
INSIDERFilingvia Quantisnow
Flexion Therapeutics, Inc. logo

SEC Form 4: Clayman Michael D. was granted 1,700 units of Common Stock, increasing direct ownership by 0.49% to 348,840 units

ByQuantisnow·Wall Street's wire, on your screen.
FLXN· Flexion Therapeutics, Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track FLXN (Flexion Therapeutics, Inc.) and more on Quantisnow.